Nicole Braccio, PharmD Candidate

Ilevro (nepafenac ophthalmic suspension) is approved to reduce pain and inflammation resulting from cataract surgery.

JAK therapies and their origins were discussed in an educational session at the 17th Annual International Congress on Hematologic Malignancies on February 15-17, 2013, in NYC.

Eliquis (apixaban) tablets are approved to reduce the risk of stroke and systemic embolism in adults with nonvalvular atrial fibrillation.

First-line treatment options and new therapies for the treatment of multiple myeloma were recently examined at the 17th International Congress on Hematologic Malignancies in NYC.